The neuroendocrine response to stressors increases the concentration of several endogenous mediators, some of which are immunosuppressive. However, quantitative aspects of these effects have been overlooked. Although it should be possible to predict the degree of suppression of particular immunological functions by measuring the concentrations of stress-related mediators such as corticosterone, this cannot be done with data presently available. This study was designed to develop regression models to predict the relationship between the area under the corticosterone concentration vs. time curve (AUC) and two immunological parameters. Models were developed using mice treated with exogenous corticosterone and mice subjected to various periods of restraint stress. The latter treatment was included to determine if the effects of corticosterone were different from those of corticosterone in association with the other mediators induced in a restraint-stress response. Models relating corticosterone AUC to expression of MHC class II proteins on splenocytes were very similar, whether the corticosterone was exogenous or produced as part of a restraintstress response. This was also true for splenic natural killer (NK) cell activity. However, MHC class II expression was more sensitive to the effects of corticosterone or restraint than was NK cell activity. The corticosterone and restraint models predicted the previously published effect of a chemical stressor (ethanol) on MHC class II expression, but neither model predicted the suppression of NK cell activity by ethanol. These results have mechanistic implications, which are discussed in the context of previous studies. The quantitative models described here should be useful in determining and predicting the stress-related portion of chemical-induced immunosuppression. In addition, these models provide quantitative data essential for a complete understanding of stress-induced immunosuppression.
increases the concentration of a number of neuroendocrine mediators, some of which can be immunosuppressive (Ader et al., 1990) . Brief or prolonged psychological stress not only suppresses immunological parameters but increases the incidence of infectious disease in humans (Herbert and Cohen, 1993; Kiecolt-Glaser et al., 1996) . Thus, the immunological effects of endogenous neuroendocrine mediators are sufficient to have an adverse impact on human health.
A number of chemicals can induce neuroendocrine stress responses in rodent models, as indicated by elevated corticosterone concentrations. Examples include: fenitrothiol (Kunimatsu et al., 1996; Yamamto et al., 1982) and other organophosphorus compounds (Clement, 1985) ; trimethyltin (Imai et al., 1998) , chlordimeform (Stoker et al., 1991) , polychlorinated biphenyls (De Krey et al., 1993; Miller et al., 1993) , unleaded gasoline (Vyskocil et al., 1988) , cadmium (Hidalgo and Armario, 1987) , mirex , propanil (Cuff et al., 1996) , paraquat (Edmonds and Edwards, 1996) , deltamethrin (de Boer et al., 1988) , carbaryl (Ray and Poddar, 1983) , gallium arsenide (Burns et al., 1994) , morphine (Freier and Fuchs, 1994; LeVier et al., 1994) , ethanol (Carson and Pruett, 1996) , haloperidol (Sullivan-Jones et al., 1992) , and phenytoin (Sullivan-Jones et al., 1992) . In some cases a stress response is only noted near the maximum tolerated dose Clement, 1985; Kunimatsu et al., 1996) . The stress response induced by some of these compounds suppresses spleen or thymus cellularity, but not selected functional immunological parameters (Burns et al., 1994; De Krey et al., 1993) . Using antagonists and other approaches, it has been shown that some compounds mediate functional immunosuppression primarily via upregulation of neuroendocrine mediators (Freier and Fuchs, 1994; Han and Pruett, 1995; Weiss et al., 1996; Pruett, 1996a,b, 1997) . However, it should be emphasized that only a small percentage of immunotoxicants have been evaluated for induction of stress responses (Pruett et al., 1993) , and few comprehensive studies have been done to definitively demonstrate the role of a particular neuroendocrine mediator in immunosuppression. Thus, it remains possible that neuroendocrine stress responses contribute to the immunotoxicity of a large number of compounds.
The biological effects of stress-induced neuroendocrine mediators are dependent on both the degree and duration of the increases in their concentration. For glucocorticoids, this may best be expressed as the area under the concentration vs. time curve (AUC), and this value usually correlates strongly with biological effect (Lew et al., 1993) . However, previous studies examining the correlation between neuroendocrine mediators and suppression of immunological parameters have not utilized corticosterone AUC values to develop predictive models. Developing such models was the major goal of the work described here. Restraint stress as well as administration of exogenous corticosterone was used in these studies, because it is clear that under some conditions glucocorticoids are not the major mediators of stress-induced immunosuppression (Keller et al., 1983) . Furthermore, under some circumstances small increases in glucocorticoid concentrations may even enhance immune functions (Stanulis et al., 1997) . Thus, comparison of the effects of exogenous corticosterone and of restraint, which induces the full spectrum of neuroendocrine mediators expected in a stress response, seemed appropriate (Ader et al., 1990; Komori et al., 1996; Yamauchi et al., 1997) .
Determining the quantitative relationship between glucocorticoid exposure and immunosuppression is not only essential for a full understanding of stress-induced immunosuppression, but it has practical implications as well. For example, toxicology testing is often done using a high dose of the test agent (at or near the maximum tolerated dose). Such doses are likely to induce a stress response, which may affect the immune system. The glucocorticoid AUC could be used to estimate at least the minimal immunosuppression expected in such cases. Because glucocorticoid concentrations can easily be measured in peripheral blood samples from humans, it should also be feasible to develop similar models in humans. This should facilitate mouse to human extrapolation of data for stress-induced immunosuppression.
MATERIALS AND METHODS
Mice. Female C57BL/6 ϫ C3H F1 (B6C3F1) mice were obtained through the National Cancer Institute's animal program, from Charles River Breeding Labs. These mice were selected because they are widely used in toxicology and immunotoxicology studies, including those sponsored by the National Toxicology Program (Luster et al., 1988) . The mice were certified by the supplier to be specific pathogen-free. Mice were allowed to recover from shipping stress for at least 2 weeks before use at the age of 8 -12 weeks. Mice were maintained on a 12-h light/dark cycle, and were given food (Purina Lab Chow) and water ad libitum.
Corticosterone administration and assay. Exogenous corticosterone was administered by subcutaneous injection in a vehicle of 2% ␤-cyclodextrin in phosphate buffered saline at dosages of 3, 9, or 18 mg/kg body weight. This protocol was developed initially because it produced corticosterone AUC values similar to those noted in mice treated with a chemical stressor (ethanol) (Weiss et al., 1996) . A group was also included that was dosed twice (at 0 and 2 h) with corticosterone at 18 mg/kg. This procedure was selected, instead of using a higher dosage, to increase the area under the corticosterone vs. time curve without increasing the peak corticosterone levels above those typically attainable in stress responses. A vehicle control group dosed at these same times was included. Mice were dosed in groups of 5 at 5-min intervals, beginning at 9:00 P.M. For each dosage of corticosterone, a separate group was bled 1, 2, 4, 6, 8, and 12 h after dosing. In addition, groups of mice dosed with vehicle or undisturbed (naive) controls were bled at the same time points. Trunk blood was obtained following decapitation and was used for corticosterone assays. It was important to bleed all mice (5) in a cage within 3 min to prevent handling-induced increases in corticosterone levels, and it was also important to avoid noise and disturbance in the animal room when removing cages for analysis. When these measures were strictly observed, corticosterone values were consistent within groups.
Blood samples were allowed to clot, and serum was removed and stored frozen until needed. Corticosterone was quantified using a commercial radioimmunoassay kit (rat corticosterone coat-a-count kit, Diagnostic Products Inc., Los Angeles, CA). The r 2 value for the standard curve was always greater than 0.95.
Restraint stress. Restraint stress was induced by placing individual mice in a 50-ml conical centrifuge tube. The tail was placed in a lengthwise slit in the tube and the mouse was then pulled into the tube by the tail. The slit in the tube also provided ventilation. The tubes were placed in the home cage during the restraint period. Each group in this study consisted of 5 mice. Mice restrained for more than 4 h were released for 10 min. after 4 h of restraint to allow access to food and water. Groups of mice were placed in restraint at the same time, and a different group was removed from the tubes and immediately bled at each of the following times after initiation of restraint: 1, 2, 4, 6, and 8 h. A naive control group was also bled at each of these time points. Other groups were released from tubes and bled one h after release (3, 5, 7, and 9 h after initiation of restraint).
Quantitation of free corticosterone. The kit used to quantitate corticosterone in this study measures total corticosterone (bound and free). The percentage of free corticosterone was determined essentially as described by MacMahon and colleagues (1983) and modified by Fleshner et al. (1995) . This method uses radiolabeled corticosterone at much lower concentrations than present in serum. The labeled corticosterone is allowed to come to equilibrium in a serum sample, so that the ratio of bound:free labeled corticosterone is the same as the ratio of bound:free endogenous (unlabeled) corticosterone. Free corticosterone is then isolated by centrifugal ultrafiltration, and the amount of labeled free corticosterone in 10 l of sample is compared to the amount of total labeled corticosterone in 10 l of a sample that was not centrifuged, to determine the percentage of free corticosterone. This was accomplished as follows: 50 l of serum was placed in a centrifugal ultrafiltration tube (10,000 MW cutoff, UFC3LGC00, Millipore Corp., Bedford, MA). Two l of 3 H-labeled corticosterone (NET-399, New England Nuclear, diluted to 25 Ci/ml in absolute ethanol) was added to each serum sample. The same amount of corticosterone was added to normal mouse serum in control tubes, but these tubes were not centrifuged. All samples were incubated for 1 h at 37°C. The rotor of a microcentrifuge was pre-heated to 37°C and the tubes were centrifuged at 2,000 ϫ g for 30 min at 37°C (this was accomplished by placing the centrifuge in an incubator). The control samples were placed into the same incubator while the other samples were centrifuged. Ten l of filtrate and a 10 l sample from unfiltered controls were taken, mixed with liquid scintillation cocktail, and the counts per minute were determined using a liquid scintillation counter. The percent free corticosterone was calculated by the following formula: % Free corticosterone ϭ cpm for 10 l of filtrate cpm for 10 l of unfiltered control ϫ 100
Calculation of the area under the corticosterone concentration vs. time curve (AUC). Corticosterone levels were determined as already described, and the data were graphed using Deltagraph software and lines without symbols. The graphs were scanned, and the digitized images were analyzed using NIH Image software (v. 1.61). The values for the x and y axes were entered, and the software calculated the area under the curve defined by the y axis on the left, the corticosterone levels from animals treated with vehicle or corticosterone as the upper line, the corticosterone values from untreated control animals as the lower line, and a vertical line at the 12-h time point (if necessary) as the border on the right side. Thus, the AUC values are based on the difference between induced and basal corticosterone levels, and undisturbed animals would have an AUC value of 0.
Expression of major histocompatibility complex (MHC) class II proteins in the spleen. Mice were treated with corticosterone or restraint stress exactly as noted above, and 12 h after the administration of corticosterone or 12 h after the initiation of restraint, spleens were obtained for analysis. This time point was selected because it is the point at which suppression of MHC class II expression by a chemical stressor (ethanol) is maximal (Weiss et al., 1996) . The expression of MHC class II proteins on splenocytes was evaluated as described previously, using flow cytometry (Weiss et al., 1996) . Briefly, anti-MHC class II antibody conjugated with fluorescein isothiocyanate (anti I-A p,b,k,q,r,s , Pharmingen, San Diego, CA) or matched isotype control antibody was incubated with splenocytes (10 6 /well) in a 96-well V-bottom microtiter plate. After centrifugation, the supernatant was aspirated and ammonium chloride erythrocyte lysis buffer was added to each well. The cells were then washed, fixed with 1% paraformaldehyde, washed again, and stored no more than 1 week, until analyzed using a Facscan flow cytometer (Becton-Dickinson). The isotype control antibody labeled less than 2% of cells in all groups analyzed. Expression of MHC class II proteins on B cells does not define a sharply delineated population of cells, but rather results in a roughly normally distributed histogram. In a previous study, we noted that the relatively small percentage of cells expressing the highest levels of MHC class II are most sensitive to stress-induced decreases (Weiss et al., 1996) . Therefore, a gate was set to include ϳ20% of splenocytes that expressed the highest levels of MHC II, and the percentage of cells in this gate was compared for each group of mice. The results are expressed as percentages of naive control values. For example, if the naive control value was 20% and the value for the treated group was 10%, the value for the treated group would be expressed as 50% of the naive control.
Assessment of splenic natural killer cell activity. Splenocytes from the same preparations used to assess MHC class II expression were used to evaluate NK cell activity using a standard 4-h 51 Cr release assay. NK cells obtained 12 h after initiation of a chemical stress response reveal maximal suppression of NK cell activity (Wu et al., 1994) . Briefly, YAC-1 target cells were labeled with 51 Cr, as described previously (Wu et al., 1994) , and labeled target cells (10 4 ) were incubated with 0.1 ml of splenocytes at 10 7 , 5 ϫ 10 6 , or 2.5 ϫ 10 6 splenocytes/ml to provide effector to target ratios of 100:1, 50:1, and 25:1. Data were expressed as lytic units per 10 7 splenocytes as described by Bryant et al. (1992) . Lytic unit values obtained in this study were all within the range reported in previous studies from this lab (Wu and Pruett, 1996b; Wu et al., 1994) , and the percent specific release values that give this range of lytic unit values are within the range reported for an interlaboratory validation study (Luster et al., 1988) . In all cases, the spontaneous release of label from YAC-1 cells was less than 10% of the maximum release of label.
Statistical and modeling methods. Free corticosterone, MHC II expression, and NK cell activity in control and treatment groups were compared by analysis of variance, followed by the Bonferroni-Dunn post-hoc test as implemented by StatView software (v4.5 for Macintosh). Mathematical models were developed by determining the effects of various dosages of corticosterone or various durations of restraint on MHC class II expression and NK cell activity in the spleen. The AUC values for the various dosages of corticosterone and for the periods of restraint were plotted against the immunological parameters. With regard to NK cell activity, the best model (as indicated by the r 2 value and a plot of residuals) was a simple linear model plotting NK cell activity vs. AUC. For MHC class II expression, a simple linear model was also best when the MHC class II data were expressed as percentages of naive control and transformed to their natural logarithms. Such transformations do not affect the fundamental relationships in the data, and they permit the use of methods of comparison that are appropriate for linear, but not for non-linear, models (Zar, 1984) . Although a quadratic model (to the 2nd power) provided a slightly better r 2 value, it was not selected, because the curve did not intersect the x axis but began to rise again beyond the last data point. Glucocorticoids have not been reported to produce such a biphasic effect on these immunological parameters; thus, quadratic models do not seem appropriate.
The models obtained using exogenous corticosterone and restraint stress were compared by plotting the 83.7% confidence intervals for the means in the model. Although it is often incorrectly assumed that points on 2 lines are significantly different at the P Ͻ 0.05 level if the 95% confidence intervals around those lines do not overlap, this level of significance is actually achieved in most cases when the 83.7% confidence intervals do not overlap (Barr, 1969; Nelson, 1989) . Thus, StatView software was used to show the 83.7% confidence intervals. This analysis was confirmed using a method described by Zar for comparing the slope and elevation of two regression lines (Zar, 1984) . The calculations were implemented using an Excel (Microsoft Corp.) spreadsheet and confirmed using software that performs the same calculation (Prism, GraphPad, San Diego, CA). The slope and other values were calculated as part of this analysis and these values matched the values obtained using StatView software. The 95% confidence interval was used to compare data obtained in this study with single values (not linear models) calculated form previously published studies.
RESULTS

Area under the Corticosterone Concentration vs. Time Curve (AUC)
The graphs shown in Figure 1 are the same as the ones used to calculate AUC, except that the symbols and error bars were omitted from the scanned images. The AUC value derived from each graph is noted, and it is clear that administration of vehicle once or twice increases the corticosterone AUC and that exogenous corticosterone dose-responsively increases the AUC values. The AUC values also increase progressively with increasing duration of restraint. It should be noted that peak corticosterone levels are similar when corticosterone at 18 mg/kg is administered once (1ϫ) or twice (at 0 and 2 h, designated 2ϫ), but the AUC is considerably greater for mice given 2 doses. AUC values also increase with increasing duration of restraint, and the peak corticosterone levels were comparable in mice restrained for 6 or 8 h and in mice treated with corticosterone at 18 mg/kg. Corticosterone levels in naive mice were similar in the exogenous corticosterone experiment and in the restraint-stress experiment. The levels shown reflect the normal murine circadian pattern, with peak corticosterone concentrations at or a few h after the beginning of the dark period.
Effect of Exogenous Corticosterone or Restraint on the Percentage of Free Corticosterone
Fleshner et al. (1995) reported that the percentage of free, biologically active corticosterone in the blood increases 24 h after exposure of rats to an acute stressor. Since such an increase could impact the immunological effects of corticosterone and thereby influence our quantitative analyses, it was important to evaluate the effects of exogenous cortico-sterone and restraint on the percentage of free vs. bound corticosterone. The results shown in Figure 2 indicate that restraint does not increase the percentage of free corticosterone. The results were the same when evaluated 3 h after an 8-h restraint session (data not shown). However, a tendency toward increased free corticosterone was noted in mice treated with the higher dosages of exogenous corticosterone. Because the increases did not exhibit a consistent pattern over time, and because they were generally small, they were not included in the mathematical model. Instead, total corticosterone was used to calculate the AUC values shown in Figure 1 , which were used in the regression models. Figure 3 illustrates the relationship between corticosterone AUC and the expression of MHC class II protein on splenocytes in mice treated with exogenous corticosterone or subjected to restraint stress. The AUC values for each dosage of corticosterone or period of restraint were obtained from the data illustrated in Figure 1 , and these were plotted against data on MHC class II expression obtained using the same experimental conditions. The data are expressed as the percent of naive control MHC class II levels transformed to the natural log (natural log values of 2.5-5.0, as shown in Figure 3 , correspond to 12.2-148.4% of control). The regression lines and the 83.7% confidence intervals are shown. The 83.7% confidence intervals overlap over the entire range covered by the data from this study. Thus, the effects of corticosterone on MHC class II expression are the same whether the corticosterone is derived by exogenous administration or endogenously as part of a full stress response. This was confirmed using a method analogous to a t-test for comparing the slope and elevation of two lines (Zar, 1984) . The slope and elevation of FIG. 1. Effect of exogenous corticosterone and restraint on corticosterone concentrations. The values shown as circles are means Ϯ SE (n, 5 mice per group) for serum corticosterone at the indicated times after administration of exogenous corticosterone or after initiation of restraint. At the indicated time points an undisturbed (naive) group (n, 5 mice per group) was also bled and evaluated for corticosterone, and the means Ϯ SE for these groups are indicated by squares. In the restraint experiment, the line segments in gray were extrapolated from available data. In the exogenous corticosterone experiment, one group was treated with vehicle (2% ␤-cyclodextrin in PBS) 1 time (Vh 1ϫ), and another group was treated twice (at 0 and 2 h) with vehicle (Vh 2ϫ). This latter group was designed as a control for the group that received 2 doses of corticosterone at 18 mg/kg (at 0 and 2 h). The area between the treated and the naive curves was measured using an image analysis program, and this represents the area under the corticosterone concentration vs. time curve used in subsequent analyses. these 2 lines are not significantly different. The AUC values and 95% confidence intervals required to produce 50% inhibition of MHC class II expression were: 3491 (2511-4876) ng/ml ⅐ h for exogenous corticosterone and 2911 (1891-4470) ng/ml ⅐ h for restraint stress. Figure 4 illustrates the relationship between corticosterone AUC and splenic NK cell activity (expressed as percent of naive control) in mice treated with exogenous corticosterone or subjected to restraint stress. The regression lines and 83.7% confidence intervals are shown. The confidence intervals overlap, indicating that there is no significant difference between the corticosterone AUC vs. NK cell activity relationship depending on whether the corticosterone was derived exogenously or as part of a restraint stress response. This was confirmed using an additional method as noted above (Zar, 1984) .
Regression Analysis of Corticosterone AUC and Suppression of Surface MHC Class II on Splenocytes
Regression Analysis of Corticosterone AUC and Suppression of Splenic NK Cell Activity
The AUC values and 95% confidence intervals required to produce 50% inhibition NK cell activity were: 8585 (5046 -17431) ng/ml ⅐ h for exogenous corticosterone and 8170 (3132-31,784) ng/ml ⅐ h for restraint stress. The confidence intervals are large, because 50% inhibition does not occur within the range of data points shown and must be extrapolated further along the line. As with all regression models, the confidence intervals become larger near the ends of the line.
FIG. 3.
Regression analysis of corticosterone AUC vs. MHC class II expression on splenocytes. Mice were given exogenous corticosterone (circles) and 12 h later, MHC class II expression was evaluated. The values shown are means Ϯ SE (n, 5 mice per group). From left to right, the symbols represent naive, one dose of vehicle, corticosterone at 9 mg/kg, two doses of vehicle, corticosterone at 18 mg/kg, and corticosterone at 18 mg/kg twice. Values for mice subjected to restraint are indicated by squares, and from left to right the symbols represent naive, 2 h of restraint, 4 h of restraint, 6 h of restraint, and 8 h of restraint. The regression lines (solid lines) and the 83.7% confidence intervals (dashed lines) are shown. This confidence interval was selected because comparing these intervals allows determination of significant differences at p Ͻ 0.05, as described in materials and methods. The equation for the exogenous corticosterone data is: y ϭ 4.509 -2.05110 -4 x; R 2 ϭ 0.781 (p Ͻ 0.001 that the slope ϭ 0). The equation for the restraint data is: y ϭ 4.472 -1.604E
-4 x; R 2 ϭ 0.739 (p Ͻ 0.001 that the slope ϭ 0).
FIG. 2.
Effect of exogenous corticosterone and restraint stress on the percentage of free corticosterone. The serum samples used in the experiments shown in Figure 1 were also analyzed to determine the percentage of corticosterone that is free (not bound to serum proteins). The values shown are means Ϯ SE (n, 4 -5 per group). Values significantly different from the naive control at each time point are indicated by * (p Ͻ 0.05) or ** (p Ͻ 0.01). In the exogenous corticosterone experiment vehicle was administered 1 time (Vh 1ϫ) or twice (at 0 and 2 h). Corticosterone was administered at the indicated dosages, and one group received 18 mg/kg twice (18 2ϫ, at 0 and 2 h). In the restraint experiment, blood samples were obtained immediately or 1 h after release from restraint, for the indicated period of time.
Use of the Regression Models to Predict the Effects of a Chemical Stressor (Ethanol) for which Corticosterone AUC Values Can Be Calculated from Published Data
In previous studies, we evaluated the effects of acute administration of ethanol on corticosterone levels (Carson and Pruett, 1996) , MHC class II expression (Weiss et al., 1996) , and NK cell activity Pruett, 1996a,b, 1997; Wu et al., 1994) in B6C3F1 female mice. This work was done as part of a series of studies characterizing a binge-drinking model in mice and using this model to study the effects of ethanol and the ethanolinduced stress response on the immune system. These data were used to calculate the corticosterone AUC values expected for particular dosages of ethanol (Carson and Pruett, 1996) and the degree of suppression of MHC class II expression (Weiss et al., 1996) and NK cell activity Pruett, 1996a,b,1997; Wu et al., 1994) that occurred at those ethanol dosages. The expected effect of the calculated AUC value on these immunological parameters was then determined using the linear models derived from the present study. The results of this evaluation are shown in Table 1 . The observed effect of ethanol on MHC class II expression was within the 95% confidence interval expected from both the exogenous corticosterone model and the restraint models. The observed and expected values correspond exactly in the case of the restraint model. In contrast, the observed value for suppression of NK cell activity was not within the 95% confidence interval predicted by the exogenous corticosterone model or the restraint model.
DISCUSSION
Results shown here indicate that there is a significant linear relationship between corticosterone AUC and suppression of MHC class II expression or suppression of NK cell activity. Very similar linear models describe the corticosterone AUC vs. MHC class II data, whether the corticosterone is exogenous or produced endogenously as part of the restraint stress response. Similarly, the linear models describing suppression of NK cell activity are almost the same, whether the corticosterone is exogenous or produced endogenously as part of a restraint stress response. However, the models for MHC II expression are not similar to those for suppression of NK cell activity, and the difference indicates that MHC class II expression is more sensitive to suppression by corticosterone or restraint stress than is NK cell activity.
Restraint stress induces a number of neuroendocrine mediators that can have immunosuppressive effects, including corticosterone, catecholamines, and endogenous opioids (Ader et al., 1990) . In particular, catecholamines remain elevated in mice during restraint sessions for as long as 16 h (Komori et al., 1996) . Handling and injection of corticosterone induces a brief stress response (see vehicle 1 ϫ group, Fig. 1 ), which undoubtedly includes these mediators. However, the duration a Value shown is the mean Ϯ SE for 4 independent experiments from a previously published study using an ethanol dosage of 7 g/kg (Weiss et al., 1996) . The corticosterone AUC value at this ethanol dosage was calculated from data published in another study from this lab (Carson and Pruett, 1996) . The expected effects were calculated from the data shown in Figure 3 .
b The value shown is the mean Ϯ SE for 8 independent experiments from previously published studies Pruett, 1996a,b, 1997; Wu et al., 1994) using an ethanol dosage of 6 g/kg. The corticosterone AUC value at this ethanol dosage was calculated from data published in another study from this lab (Carson and Pruett, 1996) . The expected effects were calculated from the data shown in Figure 4 .
FIG. 4.
Regression analysis of corticosterone AUC vs. NK cell activity. Mice were given exogenous corticosterone (squares), and 12 h later, NK cell activity was evaluated. The values shown are means Ϯ SE (n, 5 mice per group). From left to right, the symbols represent naive, 1 dose of vehicle, corticosterone at 9 mg/kg, 2 doses vehicle, corticosterone at 18 mg/kg, and corticosterone 18 mg/kg twice. Values for mice subjected to restraint are indicated by circles, and from left to right, the symbols represent naive, 2, 4, 6, and 8 h of restraint. The regression lines (solid lines) and the 83.7% confidence intervals (dashed lines) are shown. This confidence interval was selected because comparing these intervals allows determination of significant differences at p Ͻ 0.05, as described in Materials and Methods. The equation for the exogenous corticosterone data is y ϭ 110.095 -.007x; R 2 ϭ 0.391 (p ϭ 0.0002 that the slope equals 0). The equation for the restraint data is y ϭ 99.017 -.006x; R 2 ϭ 0.265 (p ϭ 0.008 that the slope equals 0).
of elevated corticosterone levels is much greater in mice given dosages of 9 or 18 mg/kg than in mice subjected only to handling and dosing stress (1 ϫ vehicle group) (Fig. 1) . Thus, in these mice, elevated corticosterone levels persist well after the handling/dosing stress response has ended. In contrast, the response to restraint stress in mice involves increased concentrations of corticosterone ( Fig. 1) and catecholamines (Komori et al., 1996) throughout the restraint period. Therefore, it is expected that immunological parameters affected primarily by corticosterone would be comparably suppressed at similar corticosterone AUC values by exogenous corticosterone and by restraint stress. In contrast, parameters affected substantially by stress-induced mediators other than corticosterone should be suppressed more by restraint than by exogenous corticosterone at equivalent corticosterone AUC values. Thus, results from the present study suggest that both MHC class II expression and splenic NK cell activity are suppressed primarily by corticosterone, at least under the conditions used here.
The results for MHC class II expression were anticipated from our previous studies with a chemical stressor (ethanol) (Weiss et al., 1996) . Experiments using a glucocorticoid antagonist or exogenous corticosterone to produce similar AUC values as produced by ethanol indicated that corticosterone was solely responsible for the suppression of MHC class II expression in ethanol-treated mice. Thus, it was not surprising that the linear models from corticosterone-treated or restrained mice both effectively predicted the suppression of MHC class II expression by ethanol (Table 1) .
Our previous studies suggest that corticosterone, catecholamines, and direct effects of ethanol are each responsible for a portion of the suppression of NK cell activity in ethanoltreated mice. Therefore, it was expected that restraint, which increases catecholamine as well as corticosterone levels (Komori et al., 1996; Kvetnansky et al., 1998; Yamauchi et al., 1997) , would produce more suppression of NK cell activity than an equivalent level of corticosterone caused by treatment with exogenous corticosterone. However, equivalent corticosterone AUC values produced comparable effects on NK cell activity, whether generated by administration of exogenous corticosterone or by restraint stress (Table 1) . This may indicate that there are quantitative, qualitative (e.g., different ratios of epinephrine and norepinephrine), or kinetic differences in the induction of catecholamines by ethanol as compared to restraint stress. Although available data in rats do not indicate substantial differences (Kvetnansky et al., 1998; Thiagarajan et al., 1989) , it is possible that such differences occur in mice. Our results are consistent with those of Freier and co-workers (1994) , who found that morphine-induced suppression of NK cell function is entirely mediated by endogenous glucocorticoids induced by morphine.
It is also possible that catecholamines or corticosterone act in synergy with ethanol to suppress NK cell activity. In this case, the effects of ethanol would be greater than the effects of restraint or exogenous corticosterone, even if corticosterone and/or catecholamine levels were comparable. Our results for NK cells seem to differ from results reported by other labs, which indicate an important role for catecholamines in stressinduced suppression of NK cell activity (Carr et al., 1993; Fecho et al., 1996; Irwin et al., 1988) . However, this catecholamine-induced suppression peaks just 1-3 h after exposure to the stressor and persists only a short period of time. In contrast, the suppression induced by a chemical stressor (Wu et al., 1994) or by corticosterone (data not shown) persists for up to 36 h. In any event, these results serve to illustrate a point that was apparent from the outset. Corticosterone AUC values induced by a chemical can be used to predict only the immunosuppression caused by the stress response to that chemical; some chemicals will produce additional immunosuppression by direct or synergistic action.
The immunological parameters evaluated in this study were selected on the basis of our previous work suggesting that the effects of stress would be entirely mediated by corticosterone (MHC II) or would involve primarily other mediators (NK cell activity). However, it should be noted that both of these parameters are important in host resistance to infection or cancer (Asadullah et al., 1995; Cheadle, 1993) . Furthermore, there is substantial evidence that a variety of stressors can suppress MHC class II expression (Weiss et al., 1996; Zwilling et al., 1990) , NK cell activity (Irwin et al., 1990 (Irwin et al., , 1987 Wu and Pruett, 1997) , and resistance to infection or cancer (Herbert and Cohen, 1993; Riley, 1975; Sheridan et al., 1991) both in animals and in humans.
A limitation of the present results is that they are applicable only to acute effects of stressors on immunological parameters measured at a selected time point. The time points used in this study are those associated with maximal suppression in response to a chemical stressor (ethanol), and preliminary experiments indicated similar time courses for mice treated with exogenous corticosterone (data not shown). Development of similar models for chronic stressors will be more difficult, but it seems feasible and may yield important information on the similarities and differences between acute and chronic effects and on the induction of tolerance or compensatory mechanisms during chronic stress.
Predictive linear models should also be applicable for animal to human extrapolation. Available data from humans and laboratory animals suggest that the effects of similar stressors on the immune system are comparable in rodents and humans (Blazar et al., 1986; Hoffman-Goetz and Pedersen, 1994; Pollock and Lotzova, 1987; Simpson and Hoffman-Goetz, 1990 ), but these data do not allow accurate extrapolation. By administering cortisol to humans, then measuring immunological parameters, it should be possible to develop models similar to those developed here in mice. The mathematical relationship between the mouse and human models should allow direct extrapolation of data obtained in mice to expected results in humans.
The inability to predict the amount of change in immuno-logical parameters that will be caused by exposure to various quantities of stress-related neuroendocrine mediators indicates a fundamental lack of understanding of the role of these mediators in regulation of the immune system. Until the quantitative activity of individual mediators and combinations of mediators is measured, it seems unlikely that it will be possible to understand or predict the different immunological effects of various stressors on the immune system. Similarly, the reasons that mild stressors often enhance immune function, whereas severe stressors are generally immunosuppressive, will likely remain elusive without such data. The studies described here represent an initial step in acquiring the quantitative data needed to understand these issues.
